| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |